Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01206153
What this trial is testing

Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients

Who this might be right for
Amenorrhea
Central South University 84
Testing effectiveness (Phase 2)Study completedNCT03818256
What this trial is testing

Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)
Corcept Therapeutics 71
Post-approval studies (Phase 4)Ended earlyNCT00712270
What this trial is testing

Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia

Who this might be right for
Schizophrenia
Kettering Health Network 21
Post-approval studies (Phase 4)UnknownNCT03080194
What this trial is testing

The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Maosheng Fang 150
Not applicableStudy completedNCT00167934
What this trial is testing

Determining Metabolic Effects of Valproate and Antipsychotic Therapy

Who this might be right for
Schizophrenia
Washington University School of Medicine 164
Not applicableStudy completedNCT00818298
What this trial is testing

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 12
Not applicableStudy completedNCT04076371
What this trial is testing

The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Beijing HuiLongGuan Hospital 1,640
Post-approval studies (Phase 4)UnknownNCT00469664
What this trial is testing

Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderCognitive Impairment
Research Foundation for Mental Hygiene, Inc. 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07152184
What this trial is testing

Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

Who this might be right for
Patient With Schizophrenia Spectrum DisorderNLM Classification WM 203, Psychology:Schizophrenic PsychologySchizophrenia Spectrum and Other Psychotic Disorders
University Hospital, Strasbourg, France 288
Testing effectiveness (Phase 2)Ended earlyNCT04421456
What this trial is testing

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Who this might be right for
Schizophrenia
Jazz Pharmaceuticals 95
Post-approval studies (Phase 4)UnknownNCT01300364
What this trial is testing

Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Fundació Sant Joan de Déu 249
Not applicableEnded earlyNCT01177709
What this trial is testing

Metformin for Weight Loss in Schizophrenia

Who this might be right for
SchizophreniaObesity
Nathan Kline Institute for Psychiatric Research 12
Post-approval studies (Phase 4)UnknownNCT00157378
What this trial is testing

Optimization of Acute Treatment in First Episode Schizophrenia

Who this might be right for
Schizophrenia, First-Episode
Ludwig-Maximilians - University of Munich 300
Early research (Phase 1)Study completedNCT00791349
What this trial is testing

QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141
Testing effectiveness (Phase 2)Ended earlyNCT00617058
What this trial is testing

Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine

Who this might be right for
Weight Gain
University of North Carolina, Chapel Hill 1
Post-approval studies (Phase 4)Study completedNCT00191555
What this trial is testing

Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

Who this might be right for
Schizophrenia
Eli Lilly and Company 360
Early research (Phase 1)Study completedNCT00796276
What this trial is testing

Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20
Post-approval studies (Phase 4)Study completedNCT00854919
What this trial is testing

Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

Who this might be right for
SSRI-Refractory Obsessive-Compulsive Disorder
Osaka City University
Large-scale testing (Phase 3)Study completedNCT01825798
What this trial is testing

Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)

Who this might be right for
OverweightAutism Spectrum Disorder
Holland Bloorview Kids Rehabilitation Hospital 60
Not applicableUnknownNCT00859664
What this trial is testing

Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders

Who this might be right for
AutismNeuroleptic Treatment
Assaf-Harofeh Medical Center 500
Next Page